Revolutionizing Breast Cancer Diagnosis with AI
Dear Thermo Oncology followers, A recent development in Breast Cancer Diagnosis with AI is amazing. Ductal carcinoma in situ (DCIS) accounts for 25% of breast
We offer breast cancer treatment by hyperthermia therapy using our proprietary hardware and software that use advanced analysis and adjustment algorithms and image processing techniques.
ThermoOncology enables a safe and effective treatment for breast cancer using targeted microwave therapy.
Combining our propriety software, TO-Plan, and hardware, the TO-M1, which use advanced algorithms and imaging, ThermoOncology plans, optimizes, targets, and executes on microwave hyperthermia therapy to mitigate breast cancer tumors.
At ThermoOncology we are dedicated to bring safe and effective cancer therapy, hyperthermia therapy, to breast cancer treatment
TO-M1 uses cameras and a specially tailored material in order to stabilize and correctly target treatment as defined during planning.
Precise region shape and depth of penetration analysis by using a combination of our proprietary wideband antenna and software
Image processing algorithm to interpret, segment, and 3D model a computational phantom of the patient using standard CT and photo imaging data.
In hyperthermia therapy, the whole or part of the patient body is subjected to a temperature in range of 40-44 ΒΊC for specific periods of time.
Since tumor cells are more sensitive to temperatures in this range, as compared to normal tissue cells, these cells are the ones that get damaged by high temperatures in this therapy.
In order to have a successful treatment outcome, it is essential to control the target cells’ temperature. Our imaging-based micro-adjustment algorithms, uses positioning, pressure, and imaging data to make corrections to the treatment in real time as the breast moves or changes shape
Read our blog to find out more about Hyperthermia therapy in cancer treatment
Dear Thermo Oncology followers, A recent development in Breast Cancer Diagnosis with AI is amazing. Ductal carcinoma in situ (DCIS) accounts for 25% of breast
Dear ThermoOncology Followers, In this post, we are discussing about the active clinical trials in the Hyperthermia treatment research in the US and Canada. If
ππππ« ππ‘ππ«π¦π¨π§ππ¨π₯π¨π π² readers, The World Health Organization (WHO) has recently published the latest global data on 36 cancers in 185 countries incidence and mortality. As
Dear #ThermoOncology Followers; In recent decades, hyperthermia has garnered significant attention as a promising approach to cancer therapy, leading to the development of more advanced
Dear #ThermoOncology Followers, How much do you know about the history of #Hyperthermia and ancient therapies? Do you know #Hyperthermia has been used as a
Dear #ThermoOncology Followers, A new review examines breast cancer patients’ attitudes towards AI in breast imaging, highlighting the importance of patient trust and acceptance. Patients prefer AI
We are here to help cancer patients throughout the world. Contact us and we will respond to your inquiry within 24 hours.
ThermoOncology offers a specialized hardware/software platform that uses advanced algorithms and imaging to plan, optimize, target, and execute on microwave hyperthermia therapy to mitigate breast cancer tumors.